Artemis Medicare Q4 FY26 Revenue Up 16.4% to ₹279 Cr, PAT Jumps 32.1%
Artemis Medicare reported Q4 FY26 consolidated revenue of ₹279 Cr (up 16.4% YoY) and PAT of ₹30 Cr (up 32.1% YoY). FY26 consolidated revenue was ₹1,081 Cr (up 15.4% YoY) with PAT at ₹104 Cr (up 26.2% YoY). The company plans to expand capacity to 1,000 beds in Gurugram and is developing new hospitals in South Delhi and Raipur, with Raipur expected by May/June 2026. It also plans to raise ₹700 crore.
The announcement includes robust financial performance figures, strategic expansion plans for multiple new hospitals, and a significant fundraising initiative, all of which have a substantial impact on the company's future growth and valuation.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT for both the quarter and the full fiscal year. Significant expansion plans and a proposed fundraising further indicate positive future prospects.
Artemis Medicare Services Limited has released its earnings presentation for the quarter and year ended March 31, 2026. The company reported a consolidated revenue from operations of ₹279 crore for Q4 FY26, marking a significant 16.4% increase year-on-year. Consolidated EBITDA rose by 23.1% to ₹59 crore, with EBITDA margins improving to 21.3% from 20.1% in the same quarter last year. Profit After Tax (PAT) saw a substantial jump of 32.1% to ₹30 crore for Q4 FY26. The consolidated diluted Earnings Per Share (EPS) for the quarter was ₹1.90, an increase of 31.0% compared to the previous year.
For the full fiscal year FY26, consolidated revenue from operations reached ₹1,081 crore, up 15.4% year-on-year. Consolidated EBITDA for FY26 was ₹218 crore, an 18.0% increase, and EBITDA margins stood at 20.2%. PAT for FY26 grew by 26.2% to ₹104 crore, with the consolidated diluted EPS at ₹6.56, an increase of 23.5% year-on-year.
On a standalone basis, net revenue from operations for Q4 FY26 was ₹27,379 lacs (₹273.79 crore), a 16.6% increase year-on-year. Standalone EBITDA for the quarter was ₹5,797 lacs (₹57.97 crore), up 21.3% year-on-year, and PAT increased by 27.3% to ₹2,955 lacs (₹29.55 crore).
The company also provided updates on its strategic growth initiatives. Artemis Hospital in Gurugram has expanded its capacity to 700 beds with the opening of its third tower and is further planning to add approximately 100+ beds through a Platinum Green Building Certification, with potential for another ~200 beds by purchasing additional FAR, aiming for a total capacity of 1,000 beds. A 650+ bed super-specialty hospital is planned in South Delhi, with an expected operational date in FY 2029. Additionally, a 300+ bed super-specialty hospital is announced for Raipur, Chhattisgarh, with an expected operational date in May/June 2026. Overseas, Artemis is operating an 80-bed hospital in Mauritius (Artemis Curepipe Hospital) and announced plans for an 110-bed facility in Mauritius (Artemis Cascavelle Hospital) in FY27.
The company also proposes to raise approximately ₹700 crore to support its growth and capital requirements, subject to shareholders' approval.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.